Michael Saylor's Billionaire Investment Strategy: Why Bitcoin Meets the Criteria
Money

Michael Saylor's Billionaire Investment Strategy: Why Bitcoin Meets the Criteria

authorBy Vicki Robin
DateAug 24, 2026
Read Time4 min

Michael Saylor, a prominent figure in the investment world and executive chairman of Strategy, recently shared his unique investment philosophy, which he terms the 'Bernard Arnault test.' This framework helps determine if an asset is worthy of substantial investment, primarily by evaluating its long-term appeal to highly successful and sophisticated individuals. Saylor firmly believes that Bitcoin stands up to this rigorous test, positioning it as a valuable asset for those aiming to invest like billionaires. His methodology encourages a forward-looking perspective, prioritizing future demand from an elite class of buyers over short-term market fluctuations or perceived discounts.

The 'Bernard Arnault test' draws its name from Bernard Arnault, the chairman of LVMH Moët Hennessy Louis Vuitton, a conglomerate that oversees 75 luxury brands including Louis Vuitton, Sephora, and Tiffany & Co. Arnault is recognized by Forbes as one of the wealthiest individuals globally, with an estimated net worth exceeding $142 billion. Saylor employs Arnault's name to symbolize the apex of wealth, representing investors who possess immense capital and refined taste. The core principle of this test revolves around a singular question: Will individuals who are wealthier, more intelligent, and more cultivated than oneself still desire to acquire this asset a decade from now? This guiding question shifts investment focus from seeking out immediate bargains to identifying assets with enduring allure and appreciation potential.

Saylor's rationale behind this investment strategy discourages chasing cheap deals and instead promotes allocating capital into assets that will continue to attract wealthier buyers in the future. He has consistently championed this perspective, often characterizing Bitcoin as a form of stored monetary energy. While Bernard Arnault himself has not publicly endorsed Bitcoin, nor has LVMH disclosed any holdings in the cryptocurrency, Saylor uses him as a benchmark for discerning taste and long-term value, rather than implying Arnault's direct involvement in the crypto market. This highlights Saylor's belief in Bitcoin's intrinsic value and its capacity to appeal to high-net-worth investors over time.

Strategy, under Saylor's leadership, initiated its Bitcoin acquisition strategy six years ago, with its first purchase on August 10, 2020, acquiring 21,454 BTC at an average price of $11,652 per coin. As of a recent Monday, Bitcoin's value hovered around $77,313, marking a significant 20.8% increase over the preceding month, despite still being approximately 39% below its all-time high of $126,080, achieved in October 2025. The company's current holdings amount to 840,447 BTC, with an average acquisition cost of $75,385 per coin. This recent market surge has placed their position roughly 2.5% in profit, translating to approximately $1.6 billion in unrealized gains. However, not all coins have been retained; on August 10, exactly six years after their initial acquisition, Strategy sold 1,690 Bitcoin at $64,262 each to support its STRC preferred shares, which were trading below their par value of $100. This divestment occurred just days before the recent market upswing.

The MSTR stock saw a recovery last week, erasing a two-month loss as crypto-related equities experienced a general rise. Despite this, critics, such as Peter Schiff, a staunch advocate for gold and founder of Euro Pacific Capital, have advised investors to divest from both Bitcoin and Strategy stock, especially as gold reached a high of over $4,400 an ounce this month. Saylor, on the other hand, has made bold predictions, forecasting a potential $12 million value for a single Bitcoin. His 'Arnault test' therefore challenges investors to assess Bitcoin's value based on projected demand in 2036, rather than current market trends. The more complex question lies in identifying who these future buyers will be and whether they will bring new capital or simply represent existing holders engaging in further transactions.

In essence, Michael Saylor's 'Bernard Arnault test' offers a compelling long-term investment framework, particularly relevant for assets like Bitcoin. By focusing on the enduring appeal to the wealthiest and most discerning future investors, Saylor provides a strategic lens through which to evaluate potential growth. This approach underscores the importance of intrinsic value and sustained demand, rather than succumbing to short-term market volatility. The continued performance of Strategy's Bitcoin holdings and the broader crypto market will serve as an ongoing testament to the validity of this unique investment philosophy.

More Articles
Money
UBS Revises S&P 500 Forecast Upwards for 2026
UBS Global Wealth Management has revised its S&P 500 targets upwards for late 2026 and mid-2027, citing robust corporate earnings and the expanding influence of AI across diverse sectors. The firm now projects an 8,100 target for year-end 2026 and 8,400 for mid-2027, maintaining a positive outlook on U.S. equities despite recent market volatility.
By Bola SokunbiAug 23, 2026
Money
The Spirits Industry Faces Headwinds as Blue Spirits Distilling Files for Chapter 7 Bankruptcy
The liquor industry is experiencing a notable downturn, with overall sales declining and many craft distilleries closing their doors. This trend is highlighted by Blue Spirits Distilling's Chapter 7 bankruptcy filing, signaling a direct liquidation of assets rather than a restructuring effort. The company's financial struggles and legal disputes underscore broader challenges within the sector, including decreasing consumer confidence and persistent economic pressures.
By Mr. Money MustacheAug 23, 2026
Money
Druckenmiller's High-Conviction Investment in Natera: A Deep Dive into Cancer Diagnostics
Billionaire investor Stanley Druckenmiller has made Natera (NTRA), a cancer-testing company, his largest holding, comprising 16.6% of his reported portfolio. His continued investment, even as shares trade near record highs, signals his strong conviction in the company's growth trajectory, particularly its Signatera blood test for cancer recurrence. Natera's robust Q2 2026 results, with revenue up 37.7% and oncology test volumes surging by 57.2%, underscore the potential of diagnostics in a resilient healthcare sector.
By Scott PapeAug 23, 2026
Money
Micron's Cycle-Free Future: A Transformative Bet on AI and Research
Micron CEO Sanjay Mehrotra is championing a future where memory chip cycles are a thing of the past, investing $10 billion into a research institution in Boise, Idaho. This bold move, driven by the increasing integration of AI, aims to revolutionize the memory industry, shifting from traditional boom-bust cycles to long-term strategic partnerships. While the market remains skeptical, viewing memory as inherently cyclical, Micron's commitment to innovation and multi-year supply agreements signals a significant pivot in its business strategy.
By Bola SokunbiAug 23, 2026
Money
Zoetis's Evolving Landscape: Navigating Companion Animal Market Challenges with Diversification and Innovation
Zoetis Inc. experienced a mixed fiscal Q2 2026, with flat revenue as a dip in the U.S. companion animal sector contrasted with growth in livestock and international markets. This quarter highlighted the company's dual nature: a strong companion animal presence facing immediate headwinds and a broader animal health platform investing in future innovations. Despite challenges like reduced vet visits and increased competition, Zoetis is banking on its diverse portfolio, global reach, and a robust pipeline of new products to restore growth.
By T. Harv EkerAug 23, 2026